[Norethisterone enanthate. Studies during the use of a long-acting parenteral contraceptive].
D000311:Adrenal Glands / Q000187:drug effects; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001798:Blood Proteins; D001809:Blood Viscosity / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D003276:Contraceptives, Oral / Q000009:adverse effects / Q000494:pharmacology*; D003692:Delayed-Action Preparations; D005260:Female; D005951:Glucose Tolerance Test; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D007273:Injections, Intramuscular; D009640:Norethindrone / Q000009:adverse effects / Q000494:pharmacology*; D013927:Thrombosis / Q000139:chemically induced; D014280:Triglycerides / Q000097:blood
D001798:Blood Proteins; D003276:Contraceptives, Oral; D003692:Delayed-Action Preparations; D014280:Triglycerides; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D009640:Norethindrone
Norethisteronönanthat. Untersuchungen während der Anwendung eines langwirkenden parenteralen Kontrazeptivum.